LPCN · Lipocine Inc.

Summary

Lipocine Inc. filed an 8-K on 2026-03-10 announcing financial results via Exhibit 99.1 press release under Item 2.02, which is not deemed 'filed' under Section 18 of the Exchange Act. The filing includes Item 9.01 listing Exhibit 99.1 as the press release.

Key takeaways

• Form 8-K filed on 2026-03-10
• Item 2.02: Results of Operations disclosed
• Exhibit 99.1: Press Release announcing Financi
• Item 9.01: Financial Statements and Exhibits
• Item 2.02 not deemed 'filed' for Section 18 purposes